• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 RNA 的策略用于人类间充质基质细胞的心脏重编程。

RNA-Based Strategies for Cardiac Reprogramming of Human Mesenchymal Stromal Cells.

机构信息

Department of Cardiac Surgery, Reference and Translation Center for Cardiac Stem Cell Therapy (RTC), Rostock University Medical Center, 18057 Rostock, Germany.

Faculty of Interdisciplinary Research, Department Life, Light & Matter, University Rostock, 18059 Rostock, Germany.

出版信息

Cells. 2020 Feb 22;9(2):504. doi: 10.3390/cells9020504.

DOI:10.3390/cells9020504
PMID:32098400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072829/
Abstract

Multipotent adult mesenchymal stromal cells (MSCs) could represent an elegant source for the generation of patient-specific cardiomyocytes needed for regenerative medicine, cardiovascular research, and pharmacological studies. However, the differentiation of adult MSC into a cardiac lineage is challenging compared to embryonic stem cells or induced pluripotent stem cells. Here we used non-integrative methods, including microRNA and mRNA, for cardiac reprogramming of adult MSC derived from bone marrow, dental follicle, and adipose tissue. We found that MSC derived from adipose tissue can partly be reprogrammed into the cardiac lineage by transient overexpression of GATA4, TBX5, MEF2C, and MESP1, while cells isolated from bone marrow, and dental follicle exhibit only weak reprogramming efficiency. qRT-PCR and transcriptomic analysis revealed activation of a cardiac-specific gene program and up-regulation of genes known to promote cardiac development. Although we did not observe the formation of fully mature cardiomyocytes, our data suggests that adult MSC have the capability to acquire a cardiac-like phenotype when treated with mRNA coding for transcription factors that regulate heart development. Yet, further optimization of the reprogramming process is mandatory to increase the reprogramming efficiency.

摘要

多能成体间充质干细胞(MSCs)可能是生成用于再生医学、心血管研究和药物学研究的患者特异性心肌细胞的一种理想来源。然而,与胚胎干细胞或诱导多能干细胞相比,将成体 MSC 分化为心脏谱系是具有挑战性的。在这里,我们使用非整合方法,包括 microRNA 和 mRNA,对源自骨髓、齿槽骨和脂肪组织的成体 MSC 进行心脏重编程。我们发现,通过瞬时过表达 GATA4、TBX5、MEF2C 和 MESP1,脂肪组织来源的 MSC 可以部分重编程为心脏谱系,而骨髓和齿槽骨分离的细胞仅表现出较弱的重编程效率。qRT-PCR 和转录组分析显示心脏特异性基因程序的激活,以及已知促进心脏发育的基因的上调。尽管我们没有观察到完全成熟的心肌细胞的形成,但我们的数据表明,当用编码调节心脏发育的转录因子的 mRNA 处理时,成体 MSC 具有获得类似心肌细胞表型的能力。然而,为了提高重编程效率,有必要进一步优化重编程过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/851076b24ba1/cells-09-00504-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/bd49da0e5237/cells-09-00504-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/eabd34accf91/cells-09-00504-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/3f9b1c92617a/cells-09-00504-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/3c808f0b1021/cells-09-00504-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/3a604444d636/cells-09-00504-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/851076b24ba1/cells-09-00504-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/bd49da0e5237/cells-09-00504-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/eabd34accf91/cells-09-00504-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/3f9b1c92617a/cells-09-00504-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/3c808f0b1021/cells-09-00504-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/3a604444d636/cells-09-00504-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d6/7072829/851076b24ba1/cells-09-00504-g006.jpg

相似文献

1
RNA-Based Strategies for Cardiac Reprogramming of Human Mesenchymal Stromal Cells.基于 RNA 的策略用于人类间充质基质细胞的心脏重编程。
Cells. 2020 Feb 22;9(2):504. doi: 10.3390/cells9020504.
2
A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.对来自mRNA重编程的人类诱导多能干细胞的心脏分化进行的系统评估。
PLoS One. 2014 Jul 28;9(7):e103485. doi: 10.1371/journal.pone.0103485. eCollection 2014.
3
Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.人脂肪来源的周细胞:生物学特性及重编程为诱导多能干细胞
Cell Physiol Biochem. 2020 Apr 1;54(2):271-286. doi: 10.33594/000000219.
4
The Future of Direct Cardiac Reprogramming: Any Cocktail Variety?直接心脏重编程的未来:鸡尾酒疗法?
Int J Mol Sci. 2020 Oct 26;21(21):7950. doi: 10.3390/ijms21217950.
5
Differentiation of single cell derived human mesenchymal stem cells into cells with a neuronal phenotype: RNA and microRNA expression profile.单细胞来源的人骨髓间充质干细胞向神经细胞表型分化:RNA 和 microRNA 表达谱。
Mol Biol Rep. 2012 Apr;39(4):3995-4007. doi: 10.1007/s11033-011-1180-9. Epub 2011 Jul 20.
6
High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling.将成纤维细胞高效重编程为心肌细胞需要抑制促纤维化信号传导。
Nat Commun. 2015 Sep 10;6:8243. doi: 10.1038/ncomms9243.
7
MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.人骨髓间充质干细胞成骨分化过程中 microRNA 表达谱分析显示 Osterix 受 miR-31 调控。
Gene. 2013 Sep 15;527(1):321-31. doi: 10.1016/j.gene.2013.06.021. Epub 2013 Jul 1.
8
A comparison of pluripotency and differentiation status of four mesenchymal adult stem cells.四种间充质成体干细胞的多能性和分化状态比较。
Mol Biol Rep. 2013 May;40(5):3693-703. doi: 10.1007/s11033-012-2445-7. Epub 2012 Dec 29.
9
Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.骨髓来源的间充质基质细胞表达心脏特异性标志物,保留基质表型,并且在体外不会成为功能性心肌细胞。
Stem Cells. 2008 Nov;26(11):2884-92. doi: 10.1634/stemcells.2008-0329. Epub 2008 Aug 7.
10
A circular RNA map for human induced pluripotent stem cells of foetal origin.人类胚胎来源诱导多能干细胞的环状 RNA 图谱。
EBioMedicine. 2020 Jul;57:102848. doi: 10.1016/j.ebiom.2020.102848. Epub 2020 Jun 20.

引用本文的文献

1
Can we stop one heart from breaking: triumphs and challenges in cardiac reprogramming.能否阻止心脏破裂:心脏重编程的成功与挑战。
Curr Opin Genet Dev. 2023 Dec;83:102116. doi: 10.1016/j.gde.2023.102116. Epub 2023 Oct 3.
2
Mesenchymal stem cell engineering by ARCA analog-capped mRNA.通过ARCA类似物封端的mRNA进行间充质干细胞工程。
Mol Ther Nucleic Acids. 2023 Jul 17;33:454-468. doi: 10.1016/j.omtn.2023.07.006. eCollection 2023 Sep 12.
3
mRNA - A game changer in regenerative medicine, cell-based therapy and reprogramming strategies.

本文引用的文献

1
Association of Human iPSC Gene Signatures and X Chromosome Dosage with Two Distinct Cardiac Differentiation Trajectories.人诱导多能干细胞基因特征与 X 染色体剂量与两种不同的心脏分化轨迹相关联。
Stem Cell Reports. 2019 Nov 12;13(5):924-938. doi: 10.1016/j.stemcr.2019.09.011. Epub 2019 Oct 24.
2
Molecular Profiles of Cell-to-Cell Variation in the Regenerative Potential of Mesenchymal Stromal Cells.间充质基质细胞再生潜能中细胞间变异的分子特征
Stem Cells Int. 2019 Sep 17;2019:5924878. doi: 10.1155/2019/5924878. eCollection 2019.
3
Umbilical cord-derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data.
mRNA——再生医学、基于细胞的治疗和重编程策略的游戏规则改变者。
Adv Drug Deliv Rev. 2021 Dec;179:114002. doi: 10.1016/j.addr.2021.114002. Epub 2021 Oct 13.
4
A preview of selected articles.部分文章预览。
Stem Cells Transl Med. 2021 Mar;10(3):333-336. doi: 10.1002/sctm.21-0036.
5
mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration.mRNA 增强型细胞疗法与心血管再生。
Cells. 2021 Jan 19;10(1):187. doi: 10.3390/cells10010187.
6
Brachyury engineers cardiac repair competent stem cells.Brachyury 工程化心脏修复的多能干细胞。
Stem Cells Transl Med. 2021 Mar;10(3):385-397. doi: 10.1002/sctm.20-0193. Epub 2020 Oct 24.
脐带间充质干细胞在心血管疾病中的应用:临床前和临床数据的综述。
Cytotherapy. 2019 Oct;21(10):1007-1018. doi: 10.1016/j.jcyt.2019.04.056. Epub 2019 Sep 17.
4
Human Pluripotent Stem Cell-Derived Cardiovascular Cells: From Developmental Biology to Therapeutic Applications.人多能干细胞衍生的心血管细胞:从发育生物学到治疗应用。
Cell Stem Cell. 2019 Sep 5;25(3):311-327. doi: 10.1016/j.stem.2019.07.010.
5
Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.人诱导多能干细胞衍生心肌细胞作为遗传性心肌病模型。
Int J Mol Sci. 2019 Sep 6;20(18):4381. doi: 10.3390/ijms20184381.
6
Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System.增强间充质基质细胞免疫调节作用以治疗受免疫系统影响的疾病。
Stem Cells Int. 2019 Aug 5;2019:7219297. doi: 10.1155/2019/7219297. eCollection 2019.
7
Stem cell-based regenerative medicine.基于干细胞的再生医学。
Stem Cell Investig. 2019 Jul 18;6:19. doi: 10.21037/sci.2019.06.04. eCollection 2019.
8
Nkx2.5 Based Ventricular Programming of Murine ESC-Derived Cardiomyocytes.基于Nkx2.5的小鼠胚胎干细胞衍生心肌细胞的心室编程
Cell Physiol Biochem. 2019;53(2):337-354. doi: 10.33594/000000142.
9
Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA.基于非整合RNA的重编程技术生成诱导多能干细胞:自我复制RNA与合成mRNA的优势
Stem Cells Int. 2019 Jun 19;2019:7641767. doi: 10.1155/2019/7641767. eCollection 2019.
10
Adipose tissue derived mesenchymal stem cells are better respondents to TGFβ1 for in vitro generation of cardiomyocyte-like cells.脂肪组织来源的间充质干细胞对 TGFβ1 的反应更好,有利于体外生成类心肌细胞。
Mol Cell Biochem. 2019 Oct;460(1-2):53-66. doi: 10.1007/s11010-019-03570-3. Epub 2019 Jun 21.